Chemokines and atherosclerosis

被引:125
作者
Terkeltaub, R
Boisvert, VA
Curtiss, LK
机构
[1] Univ Calif San Diego, Vet Affairs Med Ctr, Dept Med, San Diego, CA 92161 USA
[2] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
关键词
D O I
10.1097/00041433-199810000-00003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The recruitment of mononuclear leukocytes, and the migration, growth and activation of macrophages, lymphocytes and smooth muscle cells within lesions, are critical features of the chronic inflammatory response that typifies atherogenesis. Chemokines are members of a superfamily of small polypeptides that mediate not only migration, but also growth and activation of leukocytes and a variety of other cells. Monocyte chemoattractant and activating protein-1 was the first chemokine to be implicated in leukocyte-mediated inflammation in atherosclerosis. This review emphasizes new information on the potential atherogenic roles of monocyte chemoattractant and activating protein-1 and several other closely related chemokines of the C-C subfamily. We focus particular attention on the newly recognized atherogenic role of a subgroup of closely related chemokines of the C-X-C subfamily that includes interleukin-8 and growth regulated oncogene a. We also discuss new studies that reveal how CD40 ligand and certain other stimuli can promote chemokine expression in atherosclerosis. Curr Opin Lipidol 9:397-405. (C) 1998 Lippincott Williams & Wilkins
引用
收藏
页码:397 / 405
页数:9
相关论文
共 116 条
[21]  
FAULL RJ, 1996, J AM SOC NEPHROL, V7, P1
[22]   Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism [J].
Frostegard, J ;
Huang, YH ;
Ronnelid, J ;
SchaferElinder, L .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (05) :963-968
[23]  
Furth R., 1992, INFLAMMATION BASIC P, P325
[24]   PLATELET FACTOR-IV INHIBITS THE MITOGENIC ACTIVITY OF VEGF(121) AND VEGF(165) USING SEVERAL CONCURRENT MECHANISMS [J].
GENGRINOVITCH, S ;
GREENBERG, SM ;
COHEN, T ;
GITAYGOREN, H ;
ROCKWELL, P ;
MAIONE, TE ;
LEVI, BZ ;
NEUFELD, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (25) :15059-15065
[25]  
GHADDAR HM, 1995, THROMB HAEMOSTASIS, V74, P943
[26]  
Gresele P, 1997, THROMB HAEMOSTASIS, V78, P1434
[27]   THE UROKINASE RECEPTOR IS REQUIRED FOR HUMAN MONOCYTE CHEMOTAXIS IN-VITRO [J].
GYETKO, MR ;
TODD, RF ;
WILKINSON, CC ;
SITRIN, RG .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (04) :1380-1387
[28]   SELECTIVE BINDING OF PLATELET FACTOR-4 TO REGIONS OF ACTIVE ANGIOGENESIS IN-VIVO [J].
HANSELL, P ;
MAIONE, TE ;
BORGSTROM, P .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 269 (03) :H829-H836
[29]   CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells [J].
Henn, V ;
Slupsky, JR ;
Gräfe, M ;
Anagnostopoulos, I ;
Förster, R ;
Müller-Berghaus, G ;
Kroczek, RA .
NATURE, 1998, 391 (6667) :591-594
[30]   In vivo, in vitro, and molecular aspects of interleukin-8 and the interleukin-8 receptors [J].
Hoch, RC ;
Schraufstatter, IU ;
Cochrane, CG .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 128 (02) :134-145